A world-class specialty biopharmaceutical company

Our ambition is to become a leading specialty biopharmaceutical company meeting the needs of patients around the world. With our market-leading asthma management products and development pipeline of treatments for asthma, COPD and allergy we’re making good progress towards achieving our goal.